Thursday, November 12, 2009

Pfizer and Wyeth merger changes vaccine R&D structure

With the take over of Wyeth, vaccine research and development will be spread to other areas of the Pfizer and Wyeth facilities. There will be five major facilities looking to capture the research and development for the company including: Pearl River, NY, Cambridge, MA, La Jolla, CA, Groton, CT and Sandwich in the UK. Wyeth has been key in the vaccine development industry, which was appealing to Pfizer, as it's viewed as a steady revenue stream as developments allow scientists to find more way to prevent illnesses. Read more here.

This is the global drug delivery partnerships meeting place, focusing on bringing together professionals seeking the latest strategies, industry updates, and networking opportunities to help position your company for a successful partnership/collaboration. Join us today on LinkedIn or Follow us on Twitter!

Share this article with your social network, just click below to share now!

No comments :

Post a Comment